This website uses cookies. By continuing to browse this website you are agreeing to our use of cookies. Find out more by reading our privacy policy. Read more
Novo Nordisk on Twitter
NovoNordiskTBL is the official Novo Nordisk A/S voice tweeting about Corporate Sustainability.
The NovoNordiskTBL Twitter account is not intended for discussions about products made by Novo Nordisk A/S. Any questions or comments specific to products should be made to your healthcare professional.
Please be aware that the NovoNordiskTBL information is not intended for a US audience.
If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in.
For other customer complaints please contact us here.
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. We are therefore not able to respond to comments that pertain to legal matters or regulatory issues.
Content
The NovoNordiskTBL Twitter account is managed by Global Triple Bottom Line Management, on behalf of colleagues across the organisation.
Availability
We will update and monitor our Twitter account during office hours, Monday to Friday. Twitter may occasionally be unavailable and we accept no responsibility for lack of service due to Twitter downtime.
Response time: Within 48 hours on weekdays.
@Replies and Direct Messages
We welcome feedback and ideas from all our followers, and endeavour to join the conversation where possible. However, we are not able to reply individually to all the messages we receive via Twitter.
We will read all @replies and Direct Messages and ensure that any emerging themes or helpful suggestions are passed to the relevant people in the organisation.
We look forward to tweeting with you.
On behalf of Novo Nordisk TBL management team.
